Raghd Rostom
Senior Associate
Raghd is a Senior Associate of Syncona Investment Management Limited.
Raghd is a Director on the Board of Kesmalea Therapeutics and an Observer on the Board of Yellowstone Biosciences. She was closely involved in the foundation of both companies, including their strategic and operational set-up.
Previously, Raghd was a core member of the healthcare practice at the Boston Consulting Group, with a particular focus on strategy and digital areas across Pharma, Biotech and Global Health sectors. Prior to BCG, Raghd completed a multidisciplinary PhD at the Wellcome Sanger Institute & University of Cambridge, bridging the fields of computational genomics, cancer and infectious disease.
Syncona portfolio companies
- Kesmalea Therapeutics (Board Member)
- Yellowstone Biosciences (Board Observer)
